WBDE(SZ:002082) Xin Lang Cai Jing·2025-10-28 02:07Core Insights - Wanbangde's stock price increased by 2.51% on October 28, reaching 15.54 CNY per share, with a total market capitalization of 9.506 billion CNY [1] - The company has seen a year-to-date stock price increase of 141.68%, with a recent decline of 0.70% over the last five trading days [1] Financial Performance - For the first half of 2025, Wanbangde reported a revenue of 579 million CNY, a year-on-year decrease of 23.15%, and a net profit attributable to shareholders of 13.4635 million CNY, down 64.29% year-on-year [2] - The company has distributed a total of 613 million CNY in dividends since its A-share listing, with 122 million CNY distributed over the last three years [2] Shareholder Information - As of June 30, Wanbangde had 39,300 shareholders, an increase of 42.08% from the previous period, with an average of 14,085 circulating shares per shareholder, a decrease of 30.25% [2] Business Overview - Wanbangde, established on March 31, 1999, and listed on November 20, 2006, is primarily engaged in the production and sales of aluminum processing products, medical devices, and the research, production, and sales of modern Chinese medicine, chemical raw materials, and chemical preparations [1] - The revenue composition of Wanbangde includes 41.63% from medical devices, 24.69% from chemical raw materials and preparations, 19.61% from other goods, and 14.07% from traditional Chinese medicine [1] Market Activity - The company has appeared on the trading leaderboard seven times this year, with the most recent instance on October 13, where it recorded a net purchase of 6.4273 million CNY [1] - The net inflow of main funds on October 28 was 1.1317 million CNY, with large orders accounting for 21.37% of total purchases [1]